Evidence map›Paper›PMID 33970904›Full record

ArticlePLoS neglected tropical diseases2021

Insecticide resistance status and mechanisms in Aedes aegypti populations from Senegal.

Ndeye Marie Sene, Konstantinos Mavridis, El Hadji Ndiaye, Cheikh Tidiane Diagne, Alioune Gaye, El Hadji Malick Ngom, Yamar Ba, Diawo Diallo, John Vontas, Ibrahima Dia and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Direct Detection ofSensors (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Resistance status ofNarra J · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Ndeye Marie SeneMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
Konstantinos MavridisInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Crete, Greece.ORCID 0000-0001-9544-9510
El Hadji NdiayeMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
Cheikh Tidiane DiagneMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.ORCID 0000-0002-3499-4934
Alioune GayeMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
El Hadji Malick NgomMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
Yamar BaMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
Diawo DialloMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.ORCID 0000-0002-7478-5248
John VontasInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Crete, Greece.
Ibrahima DiaMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.
Mawlouth DialloMedical Zoology Pole, Institut Pasteur de Dakar, Dakar, Sénégal.ORCID 0000-0002-8972-0500
Institut Pasteur de Dakar · SNAgricultural University of Athens · GRFoundation for Research and Technology Hellas · GRMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aedes aegypti is the main epidemic vector of arboviruses in Africa. In Senegal, control activities are mainly limited to mitigation of epidemics, with limited information available for Ae. aegypti populations. A better understanding of the current Ae. aegypti susceptibility status to various insecticides and relevant resistance mechanisms involved is needed for the implementation of effective vector control strategies. The present study focuses on the detection of insecticide resistance and reveals the related mechanisms in Ae. aegypti populations from Senegal. Bioassays were performed on Ae. aegypti adults from nine Senegalese localities (Matam, Louga, Barkedji, Ziguinchor, Mbour, Fatick, Dakar, Kédougou and Touba). Mosquitoes were exposed to four classes of insecticides using the standard WHO protocols. Resistance mechanisms were investigated by genotyping for pyrethroid target site resistance mutations (V1016G, V1016I, F1534C and S989P) and measuring gene expression levels of key detoxification genes (CYP6BB2, CYP9J26, CYP9J28, CYP9J32, CYP9M6, CCEae3a and GSTD4). All collected populations were resistant to DDT and carbamates except for the ones in Matam (Northern region). Resistance to permethrin was uniformly detected in mosquitoes from all areas. Except for Barkédji and Touba, all populations were characterized by a susceptibility to 0.75% Permethrin. Susceptibility to type II pyrethroids was detected only in the Southern regions (Kédougou and Ziguinchor). All mosquito populations were susceptible to 5% Malathion, but only Kédougou and Matam mosquitoes were susceptible to 0.8% Malathion. All populations were resistant to 0.05% Pirimiphos-methyl, whereas those from Louga, Mbour and Barkédji, also exhibited resistance to 1% Fenitrothion. None of the known target site pyrethroid resistance mutations was present in the mosquito samples included in the genotyping analysis (performed in > 1500 samples). In contrast, a remarkably high (20-70-fold) overexpression of major detoxification genes was observed, suggesting that insecticide resistance is mostly mediated through metabolic mechanisms. These data provide important evidence to support dengue vector control in Senegal.

Indexed as

AedesAnimalsGene ExpressionInactivation, MetabolicInsecticide ResistanceInsecticidesMosquito VectorsPyrethrinsSenegalInsecticidesPyrethrins

Identifiers

PMID33970904
PMCPMC8136859
OpenAlexW3160392895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.